Copyright Reports & Markets. All rights reserved.

Global Cholesterol-lowering Statins Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Cholesterol-lowering Statins
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cholesterol-lowering Statins Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Atorvastatin
    • 1.3.3 Fluvastatin
    • 1.3.4 Lovastatin
    • 1.3.5 Pitavastatin
    • 1.3.6 Pravastatin
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cholesterol-lowering Statins Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Cholesterol-lowering Statins Market Size & Forecast
    • 1.5.1 Global Cholesterol-lowering Statins Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Cholesterol-lowering Statins Sales Quantity (2018-2029)
    • 1.5.3 Global Cholesterol-lowering Statins Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Cholesterol-lowering Statins Product and Services
    • 2.1.4 Pfizer Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Sandoz
    • 2.2.1 Sandoz Details
    • 2.2.2 Sandoz Major Business
    • 2.2.3 Sandoz Cholesterol-lowering Statins Product and Services
    • 2.2.4 Sandoz Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Sandoz Recent Developments/Updates
  • 2.3 Amgen
    • 2.3.1 Amgen Details
    • 2.3.2 Amgen Major Business
    • 2.3.3 Amgen Cholesterol-lowering Statins Product and Services
    • 2.3.4 Amgen Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Amgen Recent Developments/Updates
  • 2.4 Jialin Pharmaceutical
    • 2.4.1 Jialin Pharmaceutical Details
    • 2.4.2 Jialin Pharmaceutical Major Business
    • 2.4.3 Jialin Pharmaceutical Cholesterol-lowering Statins Product and Services
    • 2.4.4 Jialin Pharmaceutical Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Jialin Pharmaceutical Recent Developments/Updates
  • 2.5 Topfond Pharmaceutical
    • 2.5.1 Topfond Pharmaceutical Details
    • 2.5.2 Topfond Pharmaceutical Major Business
    • 2.5.3 Topfond Pharmaceutical Cholesterol-lowering Statins Product and Services
    • 2.5.4 Topfond Pharmaceutical Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Topfond Pharmaceutical Recent Developments/Updates
  • 2.6 Lepu Biopharma
    • 2.6.1 Lepu Biopharma Details
    • 2.6.2 Lepu Biopharma Major Business
    • 2.6.3 Lepu Biopharma Cholesterol-lowering Statins Product and Services
    • 2.6.4 Lepu Biopharma Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Lepu Biopharma Recent Developments/Updates
  • 2.7 Qilu Pharmaceutical
    • 2.7.1 Qilu Pharmaceutical Details
    • 2.7.2 Qilu Pharmaceutical Major Business
    • 2.7.3 Qilu Pharmaceutical Cholesterol-lowering Statins Product and Services
    • 2.7.4 Qilu Pharmaceutical Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.8 Dawnrays Pharmaceutical
    • 2.8.1 Dawnrays Pharmaceutical Details
    • 2.8.2 Dawnrays Pharmaceutical Major Business
    • 2.8.3 Dawnrays Pharmaceutical Cholesterol-lowering Statins Product and Services
    • 2.8.4 Dawnrays Pharmaceutical Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Dawnrays Pharmaceutical Recent Developments/Updates
  • 2.9 Hunan Dinuo Pharmaceutical
    • 2.9.1 Hunan Dinuo Pharmaceutical Details
    • 2.9.2 Hunan Dinuo Pharmaceutical Major Business
    • 2.9.3 Hunan Dinuo Pharmaceutical Cholesterol-lowering Statins Product and Services
    • 2.9.4 Hunan Dinuo Pharmaceutical Cholesterol-lowering Statins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Hunan Dinuo Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Cholesterol-lowering Statins by Manufacturer

  • 3.1 Global Cholesterol-lowering Statins Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Cholesterol-lowering Statins Revenue by Manufacturer (2018-2023)
  • 3.3 Global Cholesterol-lowering Statins Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Cholesterol-lowering Statins by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Cholesterol-lowering Statins Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Cholesterol-lowering Statins Manufacturer Market Share in 2022
  • 3.5 Cholesterol-lowering Statins Market: Overall Company Footprint Analysis
    • 3.5.1 Cholesterol-lowering Statins Market: Region Footprint
    • 3.5.2 Cholesterol-lowering Statins Market: Company Product Type Footprint
    • 3.5.3 Cholesterol-lowering Statins Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cholesterol-lowering Statins Market Size by Region
    • 4.1.1 Global Cholesterol-lowering Statins Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Cholesterol-lowering Statins Consumption Value by Region (2018-2029)
    • 4.1.3 Global Cholesterol-lowering Statins Average Price by Region (2018-2029)
  • 4.2 North America Cholesterol-lowering Statins Consumption Value (2018-2029)
  • 4.3 Europe Cholesterol-lowering Statins Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Cholesterol-lowering Statins Consumption Value (2018-2029)
  • 4.5 South America Cholesterol-lowering Statins Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Cholesterol-lowering Statins Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Cholesterol-lowering Statins Sales Quantity by Type (2018-2029)
  • 5.2 Global Cholesterol-lowering Statins Consumption Value by Type (2018-2029)
  • 5.3 Global Cholesterol-lowering Statins Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Cholesterol-lowering Statins Sales Quantity by Application (2018-2029)
  • 6.2 Global Cholesterol-lowering Statins Consumption Value by Application (2018-2029)
  • 6.3 Global Cholesterol-lowering Statins Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Cholesterol-lowering Statins Sales Quantity by Type (2018-2029)
  • 7.2 North America Cholesterol-lowering Statins Sales Quantity by Application (2018-2029)
  • 7.3 North America Cholesterol-lowering Statins Market Size by Country
    • 7.3.1 North America Cholesterol-lowering Statins Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Cholesterol-lowering Statins Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Cholesterol-lowering Statins Sales Quantity by Type (2018-2029)
  • 8.2 Europe Cholesterol-lowering Statins Sales Quantity by Application (2018-2029)
  • 8.3 Europe Cholesterol-lowering Statins Market Size by Country
    • 8.3.1 Europe Cholesterol-lowering Statins Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Cholesterol-lowering Statins Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cholesterol-lowering Statins Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Cholesterol-lowering Statins Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Cholesterol-lowering Statins Market Size by Region
    • 9.3.1 Asia-Pacific Cholesterol-lowering Statins Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Cholesterol-lowering Statins Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Cholesterol-lowering Statins Sales Quantity by Type (2018-2029)
  • 10.2 South America Cholesterol-lowering Statins Sales Quantity by Application (2018-2029)
  • 10.3 South America Cholesterol-lowering Statins Market Size by Country
    • 10.3.1 South America Cholesterol-lowering Statins Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Cholesterol-lowering Statins Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cholesterol-lowering Statins Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Cholesterol-lowering Statins Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Cholesterol-lowering Statins Market Size by Country
    • 11.3.1 Middle East & Africa Cholesterol-lowering Statins Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Cholesterol-lowering Statins Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Cholesterol-lowering Statins Market Drivers
  • 12.2 Cholesterol-lowering Statins Market Restraints
  • 12.3 Cholesterol-lowering Statins Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cholesterol-lowering Statins and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cholesterol-lowering Statins
  • 13.3 Cholesterol-lowering Statins Production Process
  • 13.4 Cholesterol-lowering Statins Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cholesterol-lowering Statins Typical Distributors
  • 14.3 Cholesterol-lowering Statins Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cholesterol-lowering Statins market size was valued at USD 2483.9 million in 2022 and is forecast to a readjusted size of USD 3128.2 million by 2029 with a CAGR of 3.3% during review period.
    Cholesterol-lowering statins are a class of medications specifically designed to reduce elevated levels of cholesterol in the bloodstream, thereby lowering the risk of cardiovascular diseases. Statins are one of the most commonly prescribed cholesterol-lowering drugs. They work by inhibiting an enzyme involved in cholesterol synthesis in the liver. Some well-known statins include atorvastatin, simvastatin, and rosuvastatin.
    Cholesterol-lowering statins are a widely marketed class of drugs used to treat high cholesterol and cardiovascular diseases globally. The market for these drugs is substantial, with sales steadily increasing, reflecting the growing concern and demand for cardiovascular health. In the future, the development prospects for statins are promising, and specific uses may expand into areas such as cardiovascular disease prevention and metabolic syndrome. Additionally, ongoing advancements in biotechnology are expected to drive the research and development of innovative drugs, enhancing treatment efficacy.
    The Global Info Research report includes an overview of the development of the Cholesterol-lowering Statins industry chain, the market status of Hospital (Atorvastatin, Fluvastatin), Clinic (Atorvastatin, Fluvastatin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cholesterol-lowering Statins.
    Regionally, the report analyzes the Cholesterol-lowering Statins markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cholesterol-lowering Statins market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Cholesterol-lowering Statins market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cholesterol-lowering Statins industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Atorvastatin, Fluvastatin).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cholesterol-lowering Statins market.
    Regional Analysis: The report involves examining the Cholesterol-lowering Statins market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cholesterol-lowering Statins market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Cholesterol-lowering Statins:
    Company Analysis: Report covers individual Cholesterol-lowering Statins manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cholesterol-lowering Statins This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
    Technology Analysis: Report covers specific technologies relevant to Cholesterol-lowering Statins. It assesses the current state, advancements, and potential future developments in Cholesterol-lowering Statins areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cholesterol-lowering Statins market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Cholesterol-lowering Statins market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Atorvastatin
    Fluvastatin
    Lovastatin
    Pitavastatin
    Pravastatin
    Others
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    Pfizer
    Sandoz
    Amgen
    Jialin Pharmaceutical
    Topfond Pharmaceutical
    Lepu Biopharma
    Qilu Pharmaceutical
    Dawnrays Pharmaceutical
    Hunan Dinuo Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cholesterol-lowering Statins product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cholesterol-lowering Statins, with price, sales, revenue and global market share of Cholesterol-lowering Statins from 2018 to 2023.
    Chapter 3, the Cholesterol-lowering Statins competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cholesterol-lowering Statins breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cholesterol-lowering Statins market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cholesterol-lowering Statins.
    Chapter 14 and 15, to describe Cholesterol-lowering Statins sales channel, distributors, customers, research findings and conclusion.

    Buy now